The Top 10 DividendRank'ed Nasdaq 100 ComponentsBy The Online Investor Staff, updated Sun., Aug. 19, 11:49 AM
|This Slide: #1 of 10|
#10. Shire Plc (Jersey) (NASDAQ:SHPG) — 0.2% YIELD
Shire is a holding company. Through its subsidiaries, Co. operates as a biotechnology company focused on serving people with rare diseases and other conditions. Co.'s portfolio covers seven therapeutic areas: Immunology, Hematology, Neuroscience, Internal Medicine (IM), Genetic Diseases, Oncology, and Ophthalmics. Some of Co.'s marketed products include GAMMAGARD, HYQVIA and CINRYZE for Immunology, ADVATE/ADYNOVATE, VONVENDI and FEIBA for Hematology, VYVANSE and ADDERALL XR for Neuroscience, LIALDA/MEZAVANT and PENTASA for IM, ELAPRASE and REPLAGAL for Genetic Diseases, ONCASPAR and ONYVIDE for Oncology and XIIDRA for Ophthalmics.
Strong Buy (3.62 out of 4)
(ranked higher than approx. 70% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite